Semi‐quantitative Analysis of DNA Topoisomerase‐I mRNA Level Using Reverse Transcription‐Polymerase Chain Reaction in Cancer Cell Lines: Its Relation to Cytotoxicity against Camptothecin Derivative

Expression of DNA topoisomerase (Topo)‐I mRNA in various cancer cell lines was detected using the reverse transcription‐polymerase chain reaction (RT‐PCR) method. The cytoplasmic polyadenylated RNA isolated from cancer cell lines was reverse‐transcribed and the complementary DNA was amplified by PCR primed with Topo‐I specific primers. Fidelity of the amplified sequence was confirmed by restriction endonuclease digestion and Southern blot hybridization. The level of Topo‐I mRNA was correlated positively with the cytotoxicity of a Topo‐I inhibitor, a camptothecin derivative. This RT‐PCR method may be applicable to the assessment of sensitivity of cells to Topo‐I targeted drugs, especially when only small quantities of cell samples are available.

[1]  E K Rowinsky,et al.  The current status of camptothecin analogues as antitumor agents. , 1993, Journal of the National Cancer Institute.

[2]  D. V. Von Hoff,et al.  Clinical trials with the topoisomerase I inhibitors. , 1992, Seminars in oncology.

[3]  T. Tamaya,et al.  Augmentation of antiproliferative activity of CPT‐11, a new derivative of camptothecin, by tumor necrosis factor against proliferation of gynecologic tumor cell lines , 1991, Anti-Cancer Drugs.

[4]  T. Tsuruo,et al.  Elevated expression of DNA topoisomerase II in camptothecin-resistant human tumor cell lines. , 1990, Cancer research.

[5]  T. Tsuruo,et al.  Decreased expression of DNA topoisomerase I in camptothecin-resistant tumor cell lines as determined by a monoclonal antibody. , 1990, Cancer research.

[6]  R. Hertzberg,et al.  Development of a stable camptothecin-resistant subline of P388 leukemia with reduced topoisomerase I content. , 1990, Molecular pharmacology.

[7]  D. Gelfand,et al.  1 – OPTIMIZATION OF PCRs , 1990 .

[8]  L. Liu,et al.  DNA topoisomerase I--targeted chemotherapy of human colon cancer in xenografts. , 1989, Science.

[9]  D. Rappolee,et al.  Novel method for studying mRNA phenotypes in single or small numbers of cells , 1989, Journal of cellular biochemistry.

[10]  J. Rossi,et al.  Detection of drug resistance in human tumors by in vitro enzymatic amplification. , 1988, Cancer research.

[11]  W. Earnshaw,et al.  cDNA cloning of human DNA topoisomerase I: catalytic activity of a 67.7-kDa carboxyl-terminal fragment. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[12]  A. McPhail,et al.  Plant Antitumor Agents. I. The Isolation and Structure of Camptothecin, a Novel Alkaloidal Leukemia and Tumor Inhibitor from Camptotheca acuminata1,2 , 1966 .